Circulating erythroblast abnormality associated with systemic pathologies may indicate bone marrow damage
Open Access
- 31 August 2021
- journal article
- Published by Aboutscience Srl in Journal of Circulating Biomarkers
- Vol. 10, 14-19
- https://doi.org/10.33393/jcb.2021.2220
Abstract
Background: The circulating rare cell population is diverse and rich in diagnostic information. Its characterization and clinical exploitation by cell-based liquid biopsy is an ongoing research task. Bone marrow is one of the major contributors to the peripheral blood rare cell population and, consequently, determines individual rare cell profiles thus depending on bone marrow health status. Bone marrow damage has been associated with aggressive or late-stage systemic diseases and egress of various bone marrow cells into the blood circulation. The association of quantity and heterogeneity of circulating erythroblast with bone marrow damage is of particular interest. Methods: Circulating CD71high/CD45-/Hoechsthigh blast cells from healthy, noncancer- and cancer-afflicted donors were enriched by CD45 depletion and analyzed by immunofluorescence microscopy. Results: A new finding of aberrant and mitotic circulating erythroid-like cells that appear similar across blood donors afflicted with various systemic pathologies is reported. Further presented is a classification of said erythroblast-like cells in nine subcategories according to morphological differences between phenotypically similar cells. Conclusion: Aberrant and mitotic bone marrow-derived rare circulating erythroid-like cells can be detected in the blood of afflicted individuals but not in healthy donors, suggesting the cause of bone marrow damage.Keywords
This publication has 30 references indexed in Scilit:
- Erythroid transcription factor EKLF/KLF1 mutation causing congenital dyserythropoietic anemia type IV in a patient of Taiwanese origin: Review of all reported cases and development of a clinical diagnostic paradigmBlood Cells, Molecules, and Diseases, 2013
- It Is All in the Blood: The Multifaceted Contribution of Circulating Progenitor Cells in Diabetic ComplicationsExperimental Diabetes Research, 2012
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and InvasionCancer Cell, 2008
- Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesisPublished by Cold Spring Harbor Laboratory ,2008
- American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast CancerJournal of Clinical Oncology, 2007
- Effects of Hypoxia on Heterotypic Macrophage InteractionsCell Cycle, 2007
- A Pooled Analysis of Bone Marrow Micrometastasis in Breast CancerThe New England Journal of Medicine, 2005
- Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant DiseasesClinical Cancer Research, 2004
- Genetic heterogeneity of single disseminated tumour cells in minimal residual cancerThe Lancet, 2002
- Congenital dyserythropoietic anaemia with erythroblastic multinuclearityJournal of Clinical Pathology, 1972